Publication | Closed Access
A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors
35
Citations
16
References
2016
Year
Tumor BiologyOncologyMedicineCancer GrowthPathologyAdvanced Solid TumorsCancer TreatmentPharmacologyMalignant DiseaseCancer ResearchJapanese Patients
| Year | Citations | |
|---|---|---|
Page 1
Page 1